These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38260860)

  • 21. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
    Stingl JC; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances and challenges in fluoropyrimidine pharmacogenomics and pharmacogenetics.
    Soong R; Diasio RB
    Pharmacogenomics; 2005 Dec; 6(8):835-47. PubMed ID: 16296946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics, pharmacogenomics and ecogenetics.
    Motulsky AG; Qi M
    J Zhejiang Univ Sci B; 2006 Feb; 7(2):169-70. PubMed ID: 16421980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.
    Bromley CM; Close S; Cohen N; Favis R; Fijal B; Gheyas F; Liu W; Lopez-Correa C; Prokop A; Singer JB; Snapir A; Tchelet A; Wang D; Goldstaub D;
    Pharmacogenomics J; 2009 Feb; 9(1):14-22. PubMed ID: 18794908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening.
    Ng D; Hong CS; Singh LN; Johnston JJ; Mullikin JC; Biesecker LG
    Genet Med; 2017 Mar; 19(3):357-361. PubMed ID: 27537706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests.
    Khan DA
    J Allergy Clin Immunol; 2016 Oct; 138(4):943-955. PubMed ID: 27720019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Pharmacogenetic Information in Food and Drug Administration Drug Labeling and the Table of Pharmacogenetic Associations.
    Cheng CM; So TW; Bubp JL
    Ann Pharmacother; 2021 Oct; 55(10):1185-1194. PubMed ID: 33384014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics: implementing personalized medicine.
    Mini E; Nobili S
    Clin Cases Miner Bone Metab; 2009 Jan; 6(1):17-24. PubMed ID: 22461093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic ancestry plays a central role in population pharmacogenomics.
    Yang HC; Chen CW; Lin YT; Chu SK
    Commun Biol; 2021 Feb; 4(1):171. PubMed ID: 33547344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetic testing in psychiatry: Perspective on clinical utility.
    Adiukwu F; Adesokun O; Essien E; Yalcin N; Ransing R; Nagendrappa S; Jatchavala C; Olakunke AB; Nawaz FA; Khan N
    Asian J Psychiatr; 2023 Aug; 86():103674. PubMed ID: 37327563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomics and Implications for Nursing Practice.
    Cheek DJ; Bashore L; Brazeau DA
    J Nurs Scholarsh; 2015 Nov; 47(6):496-504. PubMed ID: 26470020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of pharmacogenomics in supportive oncology: a patient journey.
    Nguyen DG; Morris SA; Patel JN
    Pharmacogenomics; 2022 Oct; 23(15):807-811. PubMed ID: 36239145
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial: Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities.
    Zgheib NK; Patrinos GP
    Front Pharmacol; 2020; 11():1217. PubMed ID: 32922289
    [No Abstract]   [Full Text] [Related]  

  • 36. Addressing the challenges of the clinical application of pharmacogenetic testing.
    Ikediobi ON; Shin J; Nussbaum RL; Phillips KA; ; Walsh JM; Ladabaum U; Marshall D
    Clin Pharmacol Ther; 2009 Jul; 86(1):28-31. PubMed ID: 19536122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenomics: Bench to bedside.
    Weinshilboum R; Wang L
    Discov Med; 2005 Feb; 5(25):30-6. PubMed ID: 20704920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.
    Robert J
    J Chemother; 2004 Nov; 16 Suppl 4():22-4. PubMed ID: 15688604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.